Hyperinsulinism  >>  Tekturna (aliskiren)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
NCT01103245: Aldosterone and the Metabolic Syndrome

Completed
1
69
US
Hydrochlorothiazide (HCTZ), HCTZ, Aliskiren 150 mg (ALI 150), Tekturna, Spironolactone (SPL 25), Aldactone, Aliskiren 300 mg (ALI 300), Spironolactone 50 mg (SPL 50)
Vanderbilt University Medical Center
Metabolic Diseases, Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders
07/12
09/13
SAAVE, NCT01432106: The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

Withdrawn
1
0
US
Aliskerin/Valsartan and Rampiril, Tekturna (Aliskerin), Diovan (Valsartan), Valturna (Aliskerin/Valsartan, Altace (Ramipril)
University of Michigan, Novartis Pharmaceuticals
Hypertension, Metabolic Syndrome
12/12
12/12

Download Options